Any current/future capex/capital investment/strategic investment?

The company has entered into a contract for captive power consumption and expects to start receiving power for its Haryana plant from April (Page 12). The phase two expansion for insoluble sulphur capacity is planned but deferred due to the current market slowdown. The capital expenditure for this expansion is not finalized, but the last expansion cost around INR 150 crores (Page 12). Expansion will be considered once capacity utilization crosses 90%-95%. Currently, utilization is around 75%-80% (Pages 5, 6). The management is open to exploring global alliances and partnerships but believes su

Future growth expectations in sales/revenue/volumes?

Global market expected to grow at about 2% to 2.5% annually over the next two years. Company focusing on increasing volumes by retaining and expanding business in India and international markets. Efforts underway to secure and maintain anti-dumping duties to protect market share, especially in India. Current global industry capacity utilization around 70%-75%; capacity expansion to be considered once utilization exceeds 90%-95%. Next phase expansion earmarked in Dharuhera but deferred due to market slowdown. Pricing under pressure mainly due to competition; further significant price declines a

Future growth expectations in earnings/operating earnings/profits/EPS?

Global market expected to grow at a low single-digit rate of 2% to 2.5% over the next two years. Company focused on increasing quantities through business growth in India and retaining international market share. Plans to leverage potential anti-dumping duties to support faster growth in India. Pricing under pressure globally, especially from China; not much further price decline expected. Volume growth expected but margin improvement largely dependent on stabilization of freight costs and capacity utilization. Capacity utilization currently around 75%-80%; next phase expansion planned after r

OCCL LtdQ4 FY25Chemicals & Petrochemicals

OCCL Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹152P/E: 11.2Market Cap: ₹855 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

→Global market expected to grow at about 2% to 2.5% annually over the next two years.
→Company focusing on increasing volumes by retaining and expanding business in India and international markets.
→Efforts underway to secure and maintain anti-dumping duties to protect market share, especially in India.
→Current global industry capacity utilization around 70%-75%; capacity expansion to be considered once utilization exceeds 90%-95%.
→Next phase expansion earmarked in Dharuhera but deferred due to market slowdown.
→Pricing under pressure mainly due to competition; further significant price declines are unlikely.
→Company aims to stabilize operations first and leverage efficient capacity utilization as demand recovers.
→No immediate plans to diversify beyond insoluble sulphur; focus remains on core chemical business growth.

Margin guidance

Category 3

→Global market expected to grow at a low single-digit rate of 2% to 2.5% over the next two years.
→Company focused on increasing quantities through business growth in India and retaining international market share.
→Plans to leverage potential anti-dumping duties to support faster growth in India.
→Pricing under pressure globally, especially from China; not much further price decline expected.
→Volume growth expected but margin improvement largely dependent on stabilization of freight costs and capacity utilization.
→Capacity utilization currently around 75%-80%; next phase expansion planned after reaching 90%-95% utilization.
→Margins expected to improve with better freight rates and anti-dumping duty benefits in the next 6-7 months.
→Overall, expect gradual top-line and EBITDA improvement driven by volume growth and operational efficiencies.

3 more insights locked — sign up free to unlock

Fundraise plans

- No explicit mention of any current or immediate future fundraising through debt or equity was made during the call. - The company is focused on strengthening its core chemical business after the de-merger. - Debt repayment plans include annual repayments of about INR 15 crores, aiming to reduce loan outstanding to around INR 34 crores by the end of the current year, which should be fully repaid in about 2 years. - Management emphasized maintaining financial discipline and leveraging strengths, without indicating any new borrowing or equity issuance. - Expansion capex is contingent on market conditions, and no firm commitment or timeline on further capex or related funding was provided. - Buyback is not being considered immediately due to recent de-merger and face value adjustment. Overall, no announced plans for new debt or equity fundraising were indicated in the transcript.

Order book

The transcript provided does not explicitly mention the current or expected order book or pending orders for OCCL Limited. However, some relevant insights include: - The company is working hard to get business in India and internationally. - They have submitted an application for anti-dumping duty to protect market share in India. - No new customer approvals have been received in North America in the recent quarter. - Demand environment remains challenging with major markets experiencing a slowdown. - The company hopes to capitalize on opportunities as market conditions improve. For specific figures or details on the current or expected order book, further disclosures from the company would be required beyond this transcript.

Capex plans

Yes

→The company has entered into a contract for captive power consumption and expects to start receiving power for its Haryana plant from April (Page 12).
→The phase two expansion for insoluble sulphur capacity is planned but deferred due to the current market slowdown. The capital expenditure for this expansion is not finalized, but the last expansion cost around INR 150 crores (Page 12).
→Expansion will be considered once capacity utilization crosses 90%-95%. Currently, utilization is around 75%-80% (Pages 5, 6).
→The management is open to exploring global alliances and partnerships but believes such moves depend on the core business performing better and improved market capitalization (Page 13).
→No immediate plans for buyback as the company recently underwent a demerger and reduced face value (Page 14).

How does OCCL Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1OCCL Ltd

Rev 4Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like OCCL Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio